| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
96.41(B) |
| Last
Volume: |
5,946,752 |
Avg
Vol: |
8,474,413 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,873,129 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$91,423,659 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
71 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,525 |
85,194 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$177,272 |
D/D |
(13,379) |
145,587 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & President, CRM |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,814 |
158,966 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$96,791 |
D/D |
(7,305) |
49,838 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,701 |
57,143 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$2,185,217 |
D/D |
(164,922) |
942,484 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
372,611 |
1,107,406 |
|
- |
|
| Bose Supratim |
EVP & President, Asia-Pacific |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,701 |
63,685 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$271,877 |
D/D |
(20,519) |
249,037 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,102 |
269,556 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$82,826 |
D/D |
(6,251) |
112,456 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,525 |
118,707 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2014-12-10 |
4 |
AS |
$12.64 |
$249,607 |
D/D |
(19,753) |
17,430 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2014-12-08 |
4 |
AS |
$12.90 |
$64,501 |
D/D |
(5,000) |
38,161 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-12-01 |
4 |
AS |
$12.96 |
$129,618 |
D/D |
(10,000) |
261,032 |
|
- |
|
| Lance Jean Fitterer |
SVP, Asst GC, Bus & Regions |
• • – |
2014-11-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
97,304 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2014-11-28 |
4 |
B |
$12.89 |
$150,832 |
D/D |
11,700 |
734,795 |
2.81 |
- |
|
| Lance Jean Fitterer |
SVP & Chief Compliance Officer |
• • – |
2014-11-10 |
4 |
S |
$13.40 |
$201,000 |
D/D |
(15,000) |
97,504 |
|
- |
|
| Ludwig Edward J |
Director |
• • – |
2014-11-10 |
4 |
B |
$13.38 |
$133,836 |
D/D |
10,000 |
12,323 |
2.39 |
- |
|
| Sununu John E |
Director |
• • – |
2014-11-05 |
4 |
S |
$13.38 |
$120,380 |
D/D |
(8,997) |
10,000 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-11-03 |
4 |
AS |
$13.30 |
$132,998 |
D/D |
(10,000) |
271,032 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2014-11-01 |
4 |
D |
$13.28 |
$2,139,368 |
D/D |
(161,097) |
723,095 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2014-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
341,669 |
884,192 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
281,032 |
|
- |
|
| Roux David J |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
17,750 |
|
- |
|
2007 Records found
|
|
Page 8 of 81 |
|
|
0.70 (1.03%) 
